Schmit Kathleen, Michiels Carine
URBC-NARILIS, University of Namur, Namur, Belgium.
Front Pharmacol. 2018 Dec 6;9:1345. doi: 10.3389/fphar.2018.01345. eCollection 2018.
A transmembrane protein (TMEM) is a type of protein that spans biological membranes. Many of them extend through the lipid bilayer of the plasma membrane but others are located to the membrane of organelles. The TMEM family gathers proteins of mostly unknown functions. Many studies showed that TMEM expression can be down- or up-regulated in tumor tissues compared to adjacent healthy tissues. Indeed, some TMEMs such as TMEM48 or TMEM97 are defined as potential prognostic biomarkers for lung cancer. Furthermore, experimental evidence suggests that TMEM proteins can be described as tumor suppressors or oncogenes. TMEMs, such as TMEM45A and TMEM205, have also been implicated in tumor progression and invasion but also in chemoresistance. Thus, a better characterization of these proteins could help to better understand their implication in cancer and to allow the development of improved therapy strategies in the future. This review gives an overview of the implication of TMEM proteins in cancer.
跨膜蛋白(TMEM)是一类跨越生物膜的蛋白质。其中许多蛋白贯穿质膜的脂质双层,但其他一些则定位于细胞器膜。TMEM家族汇聚了大多数功能未知的蛋白质。许多研究表明,与相邻的健康组织相比,肿瘤组织中TMEM的表达可能下调或上调。事实上,一些TMEM,如TMEM48或TMEM97,被定义为肺癌潜在的预后生物标志物。此外,实验证据表明,TMEM蛋白可被描述为肿瘤抑制因子或癌基因。TMEM,如TMEM45A和TMEM205,也与肿瘤进展、侵袭以及化疗耐药有关。因此,对这些蛋白质进行更好的表征有助于更好地理解它们在癌症中的作用,并为未来开发改进的治疗策略提供可能。本综述概述了TMEM蛋白在癌症中的作用。